<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/  dc: http://purl.org/dc/terms/  foaf: http://xmlns.com/foaf/0.1/  og: http://ogp.me/ns#  rdfs: http://www.w3.org/2000/01/rdf-schema#  schema: http://schema.org/  sioc: http://rdfs.org/sioc/ns#  sioct: http://rdfs.org/sioc/types#  skos: http://www.w3.org/2004/02/skos/core#  xsd: http://www.w3.org/2001/XMLSchema# ">
<head>
    <meta charset="utf-8" />
<script>(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","https://www.google-analytics.com/analytics.js","ga");ga("create", "UA-2231938-8", {"cookieDomain":"auto"});ga("require", "linkid", "linkid.js");ga("set", "anonymizeIp", true);ga("send", "pageview");</script>
<meta name="Generator" content="Drupal 8 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Merriweather:300|Lato:italic,700|Josefin+Sans:700,300&amp;subset=latin,latin-ext" media="all" />
<link rel="shortcut icon" href="/core/misc/favicon.ico" type="image/vnd.microsoft.icon" />

        <title>News Main | Insureintell.com</title>
        <link rel="stylesheet" media="all" href="/sites/default/files/css/css_8sMaExjWD_A0mbijmP-op-uMuKhwRYz4CREj4KGKkUY.css" />
<link rel="stylesheet" media="all" href="/sites/default/files/css/css_1Y1B2oSIZOoY9PwuutDXJWbUMhd6PYNl_37Uz1-h_t0.css" />

            
<!--[if lte IE 8]>
<script src="/sites/default/files/js/js_VtafjXmRvoUgAzqzYTA3Wrjkx9wcWhjP0G4ZnnqRamA.js"></script>
<![endif]-->

     <link href='//fonts.googleapis.com/css?family=Raleway:400,300,600' rel='stylesheet' type='text/css'>

                  </head>
<body class="fontyourface path-news">
<a href="#main-content" class="visually-hidden focusable skip-link">
    Skip to main content
</a>

  <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    
<div id="page-wrapper">
    <div id="page">
        <header id="header" class="header" role="banner" aria-label="Site header">
            <div class="section clearfix">
                
                <div class="no-mobile">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><h1><a href="/">Insureintell.com</a></h1>
</div>
      
        </div>
    </div>

  </div>
</div>
                <nav id="navigation" class="navbar replaceme menu original">
                <div class="menu-header">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><h1><a href="/">Insureintell.com</a></h1>
</div>
      
        </div>
    </div>

  </div>
 &nbsp; <div id="nav-icon"><span></span><span></span><span></span><span></span><span></span><span></span></div></div>
                    <div class="container">
                      <div>
    <div id="block-myaccount-4" class="block block-block-content block-block-content2375d52f-44f6-4332-adfd-e702741c6021">
    
        
            <div class="content">
            
            <div><h3 class="text-align-center">&nbsp;<a href="/newsfp/">News</a>&nbsp;-&nbsp;<a href="/articlesfp/">Articles</a>&nbsp;-&nbsp;<a href="/newsletter">Newsletter</a>&nbsp;-&nbsp;<a href="/contact">Contact</a>&nbsp;- <a href="/hot-notes">Hot Notes</a></h3>
</div>
      
        </div>
    </div>

  </div>

                    </div>
                </nav>
            </div>
        </header>
                    <div class="highlighted">
                <aside class="section clearfix" role="complementary">
                      <div>
    <div data-drupal-messages-fallback class="hidden"></div>

  </div>

                </aside>
            </div>
                        <div id="main-wrapper" class=" clearfix">
            <div id="main" class="clearfix">
                
                                                    <section class="section">
                        <a id="main-content" tabindex="-1"></a>
                                                                            
                        <div class="eight columns">
                              <div>
    <div id="block-light-skeleton-page-title--3" class="block block-core block-page-title-block">
    
        
            <div class="content">
            
<div class="sixteen page-title container floated ">
    <h1 class="title_page" >News Main</h2>
</div>


        </div>
    </div>
<section class="page-content container floated ">
<div class="views-element-container"><div class="js-view-dom-id-cd5a68044871ef4eaf54166951000f611a14920c9079cd9a4752b513cffb586d">
  
  
  

  
  
  

      <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="https://www.munichre.com/site/marclife-mobile/get/documents_E1527597204/marclife/assset.marclife/Documents/Publications/cost-benefit-analysis-of-underwriting-screening-WP_1-19-18.pdf">Cost-Benefit Analysis of Underwriting Screening for Opioid Risks</a></h3><p>The question we hear from underwriters is: is it financially feasible to screen all life applicants for opioid use? The intention of this paper is to provide context for these concerns by exploring various screening options, and to provide a cost-benefit analysis that can assist underwriting departments in determining when to use such screening tools. </p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/63">drugs</a>, <a href="/taxonomy/term/178">opioid abuse</a>, <a href="/taxonomy/term/252">screening</a></div></div>https://www.munichre.com/site/marclife-mobile/get/documents_E1527597204/marclif…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.genre.com/knowledge/blog/synthesis-analysis-a-robust-statistical-tool-en.html">A Robust Statistical Tool for Life Insurance Underwriting and Pricing Research</a></h3><p>As life insurers move toward accelerated or low friction underwriting, there is an increased interest in adopting emerging mortality risk prediction scores that are available almost instantaneously. </p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/91">accelerated underwriting</a>, <a href="/taxonomy/term/54">big data</a>, <a href="/taxonomy/term/57">predictive analytics</a>, <a href="/taxonomy/term/45">technology</a></div></div>http://www.genre.com/knowledge/blog/synthesis-analysis-a-robust-statistical-too…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="https://www.munichre.com/site/marclife-mobile/get/documents_E-364826261/marclife/assset.marclife/Documents/Publications/New_blood_pressure_guidelines.pdf">The 2017 Clinical Practice Guidelines for Hypertension</a></h3><p>The American College of Cardiology and The American Heart Association published the new “2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults” on November 13, 2017. The new guidelines propose lower thresholds for diagnosing and lower goals for treating hypertension than the previous recommendations of 2003, especially for individuals at high risk for adverse future cardiovascular events.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/279">cardiovascular disease</a>, <a href="/taxonomy/term/483">hypertension</a>, <a href="/taxonomy/term/115">Insurance Medicine</a></div></div>https://www.munichre.com/site/marclife-mobile/get/documents_E-364826261/marclif…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.genre.com/knowledge/publications/ri18-1-en.html">Classification Model Performance (Gen Re Risk Insights)</a></h3><p>Insurers are increasingly developing prediction models to use in their insurance processes. Often these models are using traditional techniques, but more and more we see machine learning techniques being applied.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/54">big data</a>, <a href="/taxonomy/term/131">predictive modeling</a>, <a href="/taxonomy/term/68">Risk Management (General)</a></div></div>http://www.genre.com/knowledge/publications/ri18-1-en.html</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.rgare.com/knowledge-center/media/articles/managing-risk-assessing-opportunities">Modernizing Your Application Process</a></h3><p>The time is right to "future-proof" underwriting processes.  Let’s consider six key facts.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/450">application process</a></div></div>http://www.rgare.com/knowledge-center/media/articles/managing-risk-assessing-op…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="https://www.scor.com/en/media/news-press-releases/heart-valve-diseases-how-assess-risk-manage-claims">Heart Valve Diseases: How to Assess Risk &amp; Manage Claims</a></h3><p>In a new inFORM publication, SCOR Life division experts Dephine Labojka and Dr. James Kadouch discuss the most common heart valve diseases, their etiology, and the efficiency of surgery.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/146">Claims</a>, <a href="/taxonomy/term/369">heart valve disorder</a>, <a href="/taxonomy/term/115">Insurance Medicine</a></div></div>https://www.scor.com/en/media/news-press-releases/heart-valve-diseases-how-asse…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.brokerworldmag.com/articles/articles.php?articleid=4394">Thyroid Blood Testing: Which One Is Best For Which Condition?</a></h3><p>Thyroid testing has become more sophisticated and much easier to interpret as the state of the art has progressed.  Whereas much of the old testing required a reference test in addition in order to correct for different individual body protein status, newer testing is much more sensitive and spot-on as a single reported value.  Each condition has one or two tests that make the best diagnosis as a primary test and tell the best story for diagnosis and treatment.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/66">impaired risk</a>, <a href="/taxonomy/term/482">thyroid blood test</a></div></div>http://www.brokerworldmag.com/articles/articles.php?articleid=4394</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.rgare.com/knowledge-center/media/articles/insurance-of-the-future-where-are-we-going">Insurance of the Future – Where are we Going?</a></h3><p>What disruptive forces will insurers need to confront to compete? And what changes are already upon us? A summary of the changes afoot and the transformations ahead, from consumer engagement and underwriting to claims.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/72">forecast</a>, <a href="/taxonomy/term/105">future</a>, <a href="/taxonomy/term/45">technology</a>, <a href="/taxonomy/term/53">trends</a></div></div>http://www.rgare.com/knowledge-center/media/articles/insurance-of-the-future-wh…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.genre.com/knowledge/publications/rm18-2-en.html">Rheumatoid Arthritis – Advances in Therapy</a></h3><p>Rheumatoid Arthritis (RA) is an inflammatory autoimmune polyarthritis of unknown etiology that targets the synovial tissue of movable joints. It is a member of a class of rheumatic diseases with inflammatory arthritis as a primary symptom, but it may also affect other organs of the body.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/115">Insurance Medicine</a>, <a href="/taxonomy/term/481">Rheumatoid Arthritis</a></div></div>http://www.genre.com/knowledge/publications/rm18-2-en.html</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.loma.org/Publications/Documents/Resource/Public/2018/Resource_Cover_Story_January_2018.aspx">Industry Directions: Our Annual Forecast (LOMA Resource)</a></h3><p>Life insurance companies continue to recalibrate in the face of new regulations, evolving technologies and customer expectations, and more. Of great concern are new regulations, with the (currently delayed) Department of Labor’s fiduciary rule taking center stage. Another year of low interest rates is placing pressure on profitability. Finally, insurers have no idea how tax reform, on which Congress was working at press time, might affect life insurance and retirement products that currently are tax advantaged.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/72">forecast</a>, <a href="/taxonomy/term/168">prediction</a>, <a href="/taxonomy/term/59">regulatory</a>, <a href="/taxonomy/term/53">trends</a></div></div>http://www.loma.org/Publications/Documents/Resource/Public/2018/Resource_Cover_…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.thinkadvisor.com/2018/01/15/big-data-sharing-and-predictive-modeling-5-things">Big Data Sharing and Predictive Modeling: 5 Things for Regulators to Consider</a></h3><p>The U.S. market is ready to realize this potential from these expansive technologies and networks but a regulatory pathway needs to be established to safeguard adherence to our core insurance principles and an individual’s right of privacy.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/54">big data</a>, <a href="/taxonomy/term/131">predictive modeling</a>, <a href="/taxonomy/term/59">regulatory</a>, <a href="/taxonomy/term/45">technology</a></div></div>http://www.thinkadvisor.com/2018/01/15/big-data-sharing-and-predictive-modeling…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.thinkadvisor.com/2018/01/04/cancer-deaths-fall-to-lowest-rate-in-decades-as-sm">Cancer Deaths Fall to Lowest Rate in Decades as Smoking Declines</a></h3><p>Fewer Americans are getting cancer, and more of those who do are surviving the disease, according to a new study.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/40">cancer</a>, <a href="/taxonomy/term/165">longevity</a>, <a href="/taxonomy/term/128">mortality risk</a>, <a href="/taxonomy/term/171">smoking</a></div></div>http://www.thinkadvisor.com/2018/01/04/cancer-deaths-fall-to-lowest-rate-in-dec…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.rgare.com/knowledge-center/media/articles/the-internet-of-things-key-considerations-for-life-insurers">The Internet of Things: Key Considerations for Life Insurers</a></h3><p>Smart homes, telematics devices, autonomous cars – it is clear the “Internet of Things” (IoT) is having a big impact on the property casualty insurance industry. But what are the implications for life insurers? A tour of technological advances and changing customer expectations. </p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/54">big data</a>, <a href="/taxonomy/term/88">internet of things</a>, <a href="/taxonomy/term/45">technology</a></div></div>http://www.rgare.com/knowledge-center/media/articles/the-internet-of-things-key…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.thinkadvisor.com/2017/12/21/us-life-expectancy-drops-again-amid-opioid-crisis?t=health-insurance%3Fref%3Dchannel-more-news">US Life Expectancy Drops Again Amid Opioid Crisis</a></h3><p>First time in more than 50 years that it fell twice in a row; deaths linked to synthetic opioids doubled from 2015 to 2016</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/115">Insurance Medicine</a>, <a href="/taxonomy/term/165">longevity</a>, <a href="/taxonomy/term/50">mortality</a>, <a href="/taxonomy/term/477">opioid epidemnic</a></div></div>http://www.thinkadvisor.com/2017/12/21/us-life-expectancy-drops-again-amid-opio…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="https://www.genevaassociation.org/news/digital-media/genetic-testing-could-cause-anti-selection-also-have-positive-impact-force-book">Genetic Testing Could Cause Anti-selection</a></h3><p>Christian Mumenthaler, CEO of Swiss Re, discusses the impact technology may have on longevity risk, and on the life re/insurance industry. Recorded at the 14th Global Ageing Conference in Zurich.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/199">antiselection</a>, <a href="/taxonomy/term/75">Genetics</a>, <a href="/taxonomy/term/45">technology</a>, <a href="/taxonomy/term/53">trends</a></div></div>https://www.genevaassociation.org/news/digital-media/genetic-testing-could-caus…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="https://www.soa.org/resources/experience-studies/2017/improving-business-process-survey/">Improving the New Business Process Survey Report</a></h3><p>The Improving the New Business Process Survey Subcommittee of the Society's Committee on Life Insurance Mortality &amp; Underwriting Surveys has completed their report on the results of a survey to examine the various changes life insurance companies have recently made, or are thinking of making, to improve the new business process.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/189">new business</a></div></div>https://www.soa.org/resources/experience-studies/2017/improving-business-proces…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.genre.com/knowledge/blog/stroke-in-younger-adults-have-improvements-reached-their-limit-en.html">Stroke in Younger Adults - Have Improvements Reached Their Limit?</a></h3><p>Age remains the most consistent risk factor for ischaemic stroke. Surprisingly then an estimated 10% of diagnoses are now seen in people below the age of 50.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/115">Insurance Medicine</a>, <a href="/taxonomy/term/116">Reinsurance</a>, <a href="/taxonomy/term/219">stroke</a>, <a href="/taxonomy/term/480">younger adults</a></div></div>http://www.genre.com/knowledge/blog/stroke-in-younger-adults-have-improvements-…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.rgare.com/knowledge-center/media/articles/thinking-about-critical-thinking">Underwriting and Claims: Thinking about Critical Thinking</a></h3><p>Critical thinking may be the most essential, if underappreciated, facet of any underwriting process. RGA's Mark Dion shares highlights from an Academy of Life Underwriting webcast on this topic, which he shared at RGA's Underwriting University. </p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/146">Claims</a></div></div>http://www.rgare.com/knowledge-center/media/articles/thinking-about-critical-th…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.rgare.com/knowledge-center/media/articles/genetic-testing-what-does-the-crystal-ball-really-reveal">Genetic Testing – What Does the Crystal Ball Really Reveal?</a></h3><p>Knowing the basics of genetic testing and its underlying science is the first step in understanding genetic testing’s potential impact on insurance. Genetic testing is best defined as the analysis of DNA, RNA, chromosomes, proteins and metabolites in relation to heritable risks, traits, and conditions.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/199">antiselection</a>, <a href="/taxonomy/term/75">Genetics</a>, <a href="/taxonomy/term/116">Reinsurance</a></div></div>http://www.rgare.com/knowledge-center/media/articles/genetic-testing-what-does-…</div>
    <div class="newsrow views-row"><h3 class="views-field views-field-field-link"><a href="http://www.thinkadvisor.com/2017/12/15/9-details-that-could-be-signs-of-life-insurance-fr?page_all=1">9 Details That Could Be Signs of Life Insurance Fraud</a></h3><p>Fraud has already made plenty of headlines this holiday season.</p><div class="views-field views-field-term-node-tid"><div class="field-content"><a href="/taxonomy/term/146">Claims</a>, <a href="/taxonomy/term/261">fraud</a></div></div>http://www.thinkadvisor.com/2017/12/15/9-details-that-could-be-signs-of-life-in…</div>

      <nav class="pager" role="navigation" aria-labelledby="pagination-heading--3">
    <h4 id="pagination-heading--3" class="visually-hidden">Pagination</h4>
    <ul class="pager__items js-pager__items">
                    <li class="pager__item pager__item--first">
          <a href="/news" title="Go to first page">
            <span class="visually-hidden">First page</span>
            <span aria-hidden="true">« First</span>
          </a>
        </li>
                          <li class="pager__item pager__item--previous">
          <a href="/news/page/14" title="Go to previous page" rel="prev">
            <span class="visually-hidden">Previous page</span>
            <span aria-hidden="true">‹ Previous</span>
          </a>
        </li>
                          <li class="pager__item pager__item--ellipsis" role="presentation">&hellip;</li>
                          <li class="pager__item">
                                          <a href="/news/page/11" title="Go to page 11">
            <span class="visually-hidden">
              Page
            </span>11</a>
        </li>
              <li class="pager__item">
                                          <a href="/news/page/12" title="Go to page 12">
            <span class="visually-hidden">
              Page
            </span>12</a>
        </li>
              <li class="pager__item">
                                          <a href="/news/page/13" title="Go to page 13">
            <span class="visually-hidden">
              Page
            </span>13</a>
        </li>
              <li class="pager__item">
                                          <a href="/news/page/14" title="Go to page 14">
            <span class="visually-hidden">
              Page
            </span>14</a>
        </li>
              <li class="pager__item is-active">
                                          <a href="/news/page/15" title="Current page">
            <span class="visually-hidden">
              Current page
            </span>15</a>
        </li>
              <li class="pager__item">
                                          <a href="/news/page/16" title="Go to page 16">
            <span class="visually-hidden">
              Page
            </span>16</a>
        </li>
              <li class="pager__item">
                                          <a href="/news/page/17" title="Go to page 17">
            <span class="visually-hidden">
              Page
            </span>17</a>
        </li>
              <li class="pager__item">
                                          <a href="/news/page/18" title="Go to page 18">
            <span class="visually-hidden">
              Page
            </span>18</a>
        </li>
              <li class="pager__item">
                                          <a href="/news/page/19" title="Go to page 19">
            <span class="visually-hidden">
              Page
            </span>19</a>
        </li>
                          <li class="pager__item pager__item--ellipsis" role="presentation">&hellip;</li>
                          <li class="pager__item pager__item--next">
          <a href="/news/page/16" title="Go to next page" rel="next">
            <span class="visually-hidden">Next page</span>
            <span aria-hidden="true">Next ›</span>
          </a>
        </li>
                          <li class="pager__item pager__item--last">
          <a href="/news/page/43" title="Go to last page">
            <span class="visually-hidden">Last page</span>
            <span aria-hidden="true">Last »</span>
          </a>
        </li>
          </ul>
  </nav>


  
  <div class="more-link"><a href="/news">more news</a></div>


      <footer>
      
    </footer>
  
  
</div>
</div>

</section>



  </div>

                        </div>
                    </section>
                                                    <div id="sidebar-second" class="three columns keep_right">
                        <aside class="section" role="complementary">
                              <div>
    <div id="block-sponsoredby-3" class="block block-block-content block-block-contenteeb7eb8e-af0c-451f-bbc6-c62766999270">
    
        
            <div class="content">
            
            <div><h5>sponsored by:</h5>

<table align="center" border="0" cellpadding="1" cellspacing="1" style="width: 80%;">
	<tbody>
		<tr>
			<td>
			<p style="text-align:center"><a href="http://www.rgare.com"><img alt="rag" src="/sites/default/files/2017-02/RGA.svg" text-align-center="" width="60%" /></a></p>
			</td>
		</tr>
		<tr>
			<td>
			<p style="text-align:center"><a href="https://www.scor.com"><img alt="rag" src="/sites/default/files/2020-05/Logo-SCOR-The-Art.svg" width="60%" /></a></p>
			</td>
		</tr>
		<tr>
			<td>
			<p style="text-align:center"><a href="http://www.rxhistories.com"><img alt="Milliman" src="/sites/default/files/2017-03/Milliman-1.svg" text-align:center="" width="60%" /></a></p>
			</td>
		</tr>
		<tr>
			<td>
			<p style="text-align:center"><a href="https://www.hannover-re.com"><img alt="Milliman" src="/sites/default/files/2017-02/HannoverRe.svg" width="60%" /></a></p>
			</td>
		</tr>
		<tr>
			<td>
			<p style="text-align:center"><a href="https://www.canadalife.com"><img alt="Milliman" src="/sites/default/files/2018-03/CanLife_Blue.svg" width="60%" /></a></p>
			</td>
		</tr>
	</tbody>
</table>



<hr /></div>
      
        </div>
    </div>

  </div>

                        </aside>
                    </div>
                            </div>
        </div>
        <div class="clearfix"></div>
        <footer class="site-footer">
            <div class="layout-container">
                                                    <div class="site-footer__bottom container page_footer">
                          <div>
    <div id="block-foot-3" class="block block-block-content block-block-content084078bf-6f39-47ba-bdb3-8d97b34316a4">
    
        
            <div class="content">
            
            <div><footer class="text-align-center">
<h5>Insureintell.com is an independent publication designed to provide business information and opinion to life and health insurance underwriters. It is intended to encourage discussion and further research.<br />
Insureintell.com does not recommend any specific action or risk appraisal in any individual life or health insurance application. All information and opinion published should undergo formal scrutiny by underwriting officers, medical directors, actuaries, legal counsel and other insurance professionals as appropriate.</h5>

<h5>Copyright® 2019&nbsp;Hank George, Inc. All Rights Reserved.</h5>
</footer>
</div>
      
        </div>
    </div>

  </div>

                    </div>
                            </div>
        </footer>
    </div>
</div>
  </div>

<div class="region region-page-bottom"><div id="fancy_login_dim_screen"></div><div id="fancy_login_login_box"><div id="fancy_login_form_contents"><a href="#" id="fancy_login_close_button">X</a><div id="fancy_login_user_login_block_wrapper"><form class="fancy-login-user-login-form" data-drupal-selector="fancy-login-user-login-form-3" action="/news/news/page/15" method="post" id="fancy-login-user-login-form--3" accept-charset="UTF-8">
  <div class="js-form-item form-item js-form-type-textfield form-item-name js-form-item-name">
      <label for="edit-name--3" class="js-form-required form-required">Username</label>
        <input autocorrect="none" autocapitalize="none" spellcheck="false" data-drupal-selector="edit-name" type="text" id="edit-name--3" name="name" value="" size="15" maxlength="60" class="form-text required" required="required" aria-required="true" />

        </div>
<div class="js-form-item form-item js-form-type-password form-item-pass js-form-item-pass">
      <label for="edit-pass--3" class="js-form-required form-required">Password</label>
        <input data-drupal-selector="edit-pass" type="password" id="edit-pass--3" name="pass" size="15" maxlength="128" class="form-text required" required="required" aria-required="true" />

        </div>
<input autocomplete="off" data-drupal-selector="form-7hkxtehherivo2o4wofiohslevy7-r-50pwgiqjx1ay" type="hidden" name="form_build_id" value="form-7HKXTEHHerIvo2O4WOfiOHSlEVy7-r-50PWgiqJX1aY" />
<input data-drupal-selector="edit-fancy-login-user-login-form-3" type="hidden" name="form_id" value="fancy_login_user_login_form" />
<ul data-drupal-selector="edit-user-links"><li><a href="/user/password" title="Request new password via email.">Request new password</a></li></ul><div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions--3"><input data-drupal-selector="edit-submit-1591495953" type="submit" id="edit-submit-1591495953--3" name="op" value="Log in" class="button js-form-submit form-submit" />
</div>

</form>
</div></div></div></div>
<script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"news","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","currentQuery":{"page":"14"}},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"core\/drupal.ajax,core\/html5shiv,core\/jquery.form,extlink\/drupal.extlink,fancy_login\/popup,fontyourface\/font_display_light_skeleton,google_analytics\/google_analytics,light_skeleton\/skeleton,system\/base,views\/views.module","theme":"light_skeleton","theme_token":null},"ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true,"\/news/news/page/15\u0026ajax_form=1":true},"fancyLogin":{"screenFadeColor":"grey","screenFadeZIndex":10,"loginBoxBackgroundColor":"white","loginBoxTextColor":"black","loginBoxBorderColor":"black","loginBoxBorderWidth":"1px","loginBoxBorderStyle":"solid","loginPath":"\/user\/login","dimFadeSpeed":null,"boxFadeSpeed":null,"hideObjects":false},"ajax":{"edit-submit-1591495953--3":{"callback":"fancy_login_user_login_block_ajax_callback","event":"mousedown","keypress":true,"prevent":"click","url":"\/news/news/page/15\u0026ajax_form=1","dialogType":"ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Log in"}}},"google_analytics":{"trackOutbound":true,"trackMailto":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"data":{"extlink":{"extTarget":true,"extTargetNoOverride":null,"extNofollow":null,"extFollowNoOverride":null,"extClass":"ext","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":"","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":false,"extAlertText":"","mailtoClass":"0","mailtoLabel":"(link sends email)"}},"user":{"uid":0,"permissionsHash":"9eefd52671687a581488e58f9810121b71f4049b340084fc527a3c9edd844181"}}</script>
<script src="/sites/default/files/js/js_e6-SH2JCxM0WNYs4R1vHEs5bWDpCzWT3qWBkLw5LK-Q.js"></script>

</body>
</html>
